Arch Therapeutics, Inc. Share Price
Equities
ARTH
US03939W2089
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.18 USD | +3.51% | 0.00% | -83.70% |
Sales 2022 | 0.02 1.31 | Sales 2023 | 0.08 6.32 | Capitalization | 6.1M 509M |
---|---|---|---|---|---|
Net income 2022 | -5M -417M | Net income 2023 | -6M -500M | EV / Sales 2022 | 47,34,69,716 x |
Net Debt 2022 | 2.62M 218M | Net Debt 2023 | 5.41M 451M | EV / Sales 2023 | 15,18,85,320 x |
P/E ratio 2022 |
-0.87
x | P/E ratio 2023 |
-0.57
x | Employees | 8 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.87% |
1 day | +3.51% | ||
Current month | -39.80% | ||
1 month | -39.80% | ||
3 months | -67.13% | ||
6 months | +96.67% | ||
Current year | -83.70% |
Managers | Title | Age | Since |
---|---|---|---|
Terrence Norchi
CEO | Chief Executive Officer | 59 | 16/09/16 |
Michael Abrams
DFI | Director of Finance/CFO | 55 | 10/21/10 |
Shawn Carlson
SAM | Sales & Marketing | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Terrence Norchi
CEO | Chief Executive Officer | 59 | 16/09/16 |
Fish Guy
BRD | Director/Board Member | 64 | 31/21/31 |
Laurence Hicks
BRD | Director/Board Member | - | 27/21/27 |
Date | Price | Change | Volume |
---|---|---|---|
24/24/24 | 1.18 | +3.51% | 618 |
23/24/23 | 1.14 | -3.39% | 316 |
Delayed Quote OTC Markets, April 24, 2024 at 11:28 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
-83.70% | 5.24M | |
+13.14% | 129B | |
-8.95% | 10.77B | |
+3.60% | 9.05B | |
+20.12% | 7.38B | |
+22.30% | 4.88B | |
+7.26% | 3.41B | |
-0.50% | 3.07B | |
-5.07% | 2.24B | |
-4.22% | 2.12B |
- Stock Market
- Equities
- ARTH Stock